Latest Breaking News On - Mike mcelhaugh - Page 1 : comparemela.com

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update Conference Call.

City ofUnited kingdomDavid hastingsDave hastingsMike mcelhaughBristol myers squibbMichaelj mcelhaughRoy buchananKaren simsLisa caperelliArbutus biopharma corpArbutus biopharma corporationCall transcript novemberBiopharma corporationArbutus third quarter corporateFinancial update conference

Arbutus Biopharma (ABUS) Announces CEO, William Collier, to Retire December 31

Arbutus Biopharma (ABUS) Announces CEO, William Collier, to Retire December 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Frank tortiMike mcelhaughMichaelj mcelhaughWilliam collierArbutus biopharma corporation nasdaqArbutus biopharma corporationChief executive officerChief operating officerInterim president

Arbutus Announces CEO, William Collier, to Retire December 31, 2023

Arbutus Announces CEO, William Collier, to Retire December 31, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisam caperelliMike mcelhaughOncore biopharmaWilliam collierMichaelj mcelhaughBristol myers squibbFrank tortiViropharma incBusiness developmentCo incGilead sciences incMarket analytics at pharmasset incArbutus biopharma corporation nasdaqSecurities exchangeJoseph universityThomas jefferson university

Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)

Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage

William collierFrank tortiMichaelj mcelhaughLisam caperelliOncore biopharmaMike mcelhaughBristol myers squibbSecurities exchangeBusiness developmentMarket analytics at pharmasset incGilead sciences incThomas jefferson universityArbutus biopharma corporationJoseph universityViropharma incCo inc